–Hemophilia patients frequently present with multiple comorbidities which require regular monitoring and consistent care
–Providers and payers must address the hemophilia as well as the patient’s other health issues in an efficient and cost-effective manner
–Appropriate control of the patient’s hemophilia and comorbid conditions is critical for improved outcomes
–Ease of access and timely delivery of prescribed medications can enhance compliance and contribute to the maintenance of disease control
–The Medical and Scientific Advisory Committee (MASAC) of the National Hemophilia Foundation has developed a set of standards of service for providers of clotting factor in the home